NovoNordisk AHA

Copilot said: Here is a summary for a 5th grade audience, without contractions, apostrophes, or bullet points: This study is testing a medicine called denecimig for people who need help with blood clotting because their bodies do not have enough factor VIII. Denecimig is given as a shot under the skin and is designed to do the job of factor VIII in the blood. Participants will receive the study medicine once a month for the first 12 weeks. After that, the study doctor may decide that the medicine should be given once a month, every two weeks, or every week. Participants will come to the clinic for regular visits where doctors will do blood tests and physical exams to check their health and see how well the treatment is working. The final study visit will take place about five months after the last dose of the study medicine.